Irvine, California — KB Medical Group (KBMED), a global leader in medical device innovation and manufacturing, has announced the expansion of its production capacity with a new Safety Pen-Type Blood Collection Needle (Model: SBCN-3)  line, scheduled to begin mass production in November 2025. This milestone marks a major investment in enhancing supply stability for Europe’s laboratory and hospital sectors, where the demand for safety-engineered blood collection devices continu

I rvine, California — KB Medical Group (KBMED) is proud to announce the successful shipment and delivery of a full 40-foot high-quality...

A t KB Medical Group (KBMED), we understand that families, home caregivers, and healthcare professionals are seeking solutions that...

I n our previous discussions, we explored the three key pressure technologies in Needle-Free Connectors (NFCs) : positive, negative, and...

I n high-volume clinical settings, safety is not just a feature—it’s a requirement. That’s why at KBMED , we continue to align product...

Building on its earlier announcement of Securing DGDA certification in Bangladesh , KBMED, a U.S.-based leader in enteral feeding...

KBMED is proud to announce the launch of its latest infection prevention product: the Disinfection Cap for Needleless Connectors ,...

Following a focused two-day business visit to El Salvador, Panda. W, Deputy Sales Manager and Regional Manager for North & South America,...

KBMED  proudly unveils its upgraded  Push Button Blood Collection Set , engineered to meet the high standards expected by today’s...